SCHEMBL18934878

SCHEMBL18934878

Clc1ccccc1Nc1ccc2c(c1)nc1n(-c3ccccc3)c3ccccc3n21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 6/20 0.40
MAPK10 P53779 6/20 0.40
NPC1 O15118 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
MAPK14 Q16539 2/20 0.38
KMT2A Q03164 1/20 0.37
LCK P06239 3/20 0.36
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35
MAPK11 Q15759 1/20 0.35
NR1I2 O75469 1/20 0.35
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SRC P12931 1/20 0.34
KDR P35968 1/20 0.34
TSHR P16473 1/20 0.34
APAF1 O14727 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18919880 0.92 LCK (0.42) MAPK8MAPK10NPC1MAPTRAB9A
SCHEMBL24021151 0.92 LCK (0.42) MAPK8MAPK10NPC1MAPTRAB9A
SCHEMBL20616859 0.91 LCK (0.40) MAPK8MAPK10NPC1MAPTMAPK14
SCHEMBL20616750 0.81 LMNA (0.39) NPC1RAB9AKMT2AALDH1A1TSHR
SCHEMBL24021155 0.79 KMT2A (0.41) NPC1POLBMAPTRAB9AKMT2A
SCHEMBL23652434 0.79 ADORA2B (0.48) MAPTKMT2AALDH1A1HTTL3MBTL1
SCHEMBL20616775 0.78 KMT2A (0.37) MAPK8MAPK10NPC1RAB9AKMT2A
SCHEMBL24021149 0.76 KMT2A (0.43) NPC1MAPTRAB9AKMT2ALCK
SCHEMBL18934712 0.76 KMT2A (0.43) NPC1MAPTRAB9AKMT2ALCK
SCHEMBL22662158 0.76 ADORA2B (0.44) NPC1KMT2AALDH1A1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2021-11-16 US disclosed
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-01-03 US disclosed
WO-2017093958-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2017-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes KCNH2, KCNH3, KCNJ2 MAPK8 4202/4885MAPK10 4330/4885NPC1 3664/4885
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES KCNH2, KCNH3, KCNJ2 MAPK8 4202/4885MAPK10 4330/4885NPC1 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.